PTC Therapeutics to commercialise Akcea’s two rare disease drugs
Ionis Pharmaceuticals affiliate Akcea Therapeutics has signed an agreement with biopharmaceutical company PTC Therapeutics for...
BioNTech and Genevant Sciences to develop rare disease drugs
German biopharmaceutical firm BioNTech has partnered with Genevant Sciences, a genetic disorder therapeutics maker, to...